Dutch Botanicals Face Stricter Controls; UK Ads Regulators Target Supplement Non-Compliance
The Netherlands proposes tighter botanical regulations, impacting ingredient sourcing and product portfolios for EU manufacturers, while UK advertising authorities report pervasive non-compliance in supplement marketing, particularly online.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 12 October 2026
New regulatory pressures are emerging for supplement manufacturers across Europe. The Netherlands is currently advancing proposals to impose more stringent controls on specific botanicals used in food supplements. This initiative, driven by public health concerns, will necessitate manufacturers holding updated safety data and potentially reformulating products to comply with revised maximum dosage levels or ingredient restrictions. The impact extends beyond direct market access, influencing broader EU ingredient availability and supply chain stability for certain botanical extracts.
Concurrently, the Advertising Standards Authority (ASA) in the UK has identified widespread non-compliance within the supplement sector's marketing practices, particularly concerning online promotions. The ASA's findings indicate a high prevalence of unsubstantiated health claims, efficacy misrepresentations, and inadequate disclaimers. This escalating regulatory focus signals a period of heightened enforcement, demanding immediate review and potential recalibration of current marketing strategies by brand owners operating within the UK market. Enforcement actions will likely include mandated claim removals and public sanctions, directly affecting brand reputation and sales velocity.
Beyond compliance, innovation continues to reshape ingredient supply. Projects like Those Vegan Cowboys' development of cow-free casein point towards significant shifts in protein sourcing and consumer preferences, potentially disrupting traditional dairy-derived ingredient markets. Furthermore, the industry is increasingly advocating for broadening omega-3 sources beyond conventional fish oil, driven by sustainability concerns and the need for diversified supply chains. This push aligns with consumer demand for novel, ethical, and plant-based alternatives, creating both opportunities and competitive challenges for formulators.
What this means for United Kingdom
UK brand owners face an immediate and substantial risk of enforcement action from the ASA due to current non-compliant advertising, particularly online. This necessitates an urgent audit of all marketing materials by Q4 2026 to ensure all claims are EFSA-approved or robustly substantiated, and disclaimers are prominently displayed. Reformulation costs for products containing botanicals common in the Dutch market could arise if harmonised EU regulations follow. Procurement leads must actively explore sustainable omega-3 alternatives and innovative protein sources like bio-identical casein to future-proof portfolios against supply chain vulnerabilities and capitalise on growing consumer segments for plant-based and ethical nutrition.
Mergers and acquisitions, exemplified by HTBA’s recent acquisition of Specnova, indicate a market trend towards consolidating advanced delivery systems and premium ingredient portfolios. This signals increased competition for novel, high-absorption technologies, requiring smaller brands to either innovate or risk being outmanoeuvred by larger entities with broader intellectual property and R&D capabilities.
Brand owners increasingly rely on contract-manufacturing partners such as Supplement Factory to navigate these requirements.